血细胞计数板市场（2026—2031）
血细胞计数板市场规模预计由2026年的4917.9亿美元增至2031年的6750.6亿美元，预测期复合年增长率为6.54%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
血细胞计数板市场规模预计由2026年的4917.9亿美元增至2031年的6750.6亿美元，预测期复合年增长率为6.54%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 6.54% | 机构预测 |
| 市场规模 | 2026 | USD 491.79 billion | 机构预测 |
| 市场规模 | 2031 | USD 675.06 billion | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| application | blood cell counting | 2026 | 39.650% |
| chamber_material | glass chambers | 2025 | 47.870% |
| end_user | diagnostic laboratories | 2025 | 58.650% |
| geography | North America | 2025 | 42.560% |
| product | manual hemocytometers | 2025 | 57.650% |
关键结论
- application 维度中，blood cell counting 在 2026 年的公开份额为 39.65%。
- chamber_material 维度中，glass chambers 在 2025 年的公开份额为 47.87%。
- end_user 维度中，diagnostic laboratories 在 2025 年的公开份额为 58.65%。
- geography 维度中，North America 在 2025 年的公开份额为 42.56%。
- product 维度中，manual hemocytometers 在 2025 年的公开份额为 57.65%。
主要参与者
- Merck KGaA
- Hausser Scientific Co.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- INCYTO Co., Ltd.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Cell And Gene Therapy Manufacturing Workflows | +1.500% | North America and Europe core, with spill-over to Asia-Pacific | Long term (≥ 4 years) |
| Rapid Viability And Concentration Assessment | +1.000% | Global | Medium term (2-4 years) |
| Automated Imaging And Digital Counting | +0.800% | North America, Europe, South Korea, and China | Medium term (2-4 years) |
| Biotechnology And Life-Science Research Expansion | +0.600% | Asia-Pacific core, with spill-over to Middle East and Africa | Long term (≥ 4 years) |
| Point-Of-Care White Blood Cell Testing | +0.300% | Middle East and Africa, South America, South Asia, and Southeast Asia | Medium term (2-4 years) |
| Disposable Chambers And Contamination Control | +0.500% | Global, concentrated in North America and Europe | Short term (≤ 2 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Substitution By Automated Cell Counters And Flow Cytometers | -0.800% | North America and Europe primarily | Short term (≤ 2 years) |
| Manual-Counting Variability And Operator Dependence | 0.000% | Global | Medium term (2-4 years) |
| Limited Standardization Across Chamber Designs And Protocols | -0.300% | Global, most acute in multicenter research | Long term (≥ 4 years) |
| Qualification And Data-Integrity Requirements For Digital Systems | -0.300% | North America and Europe | Medium term (2-4 years) |
报告关注的关键问题
What is the forecast value of hemocytometers market in 2031?
The Hemocytometer Market size is projected to be USD 461.60 billion in 2025, USD 491.79 billion in 2026, and reach USD 675.06 billion by 2031, growing at a CAGR of 6.54% from 2026 to 2031.
Which hemocytometer product category leads revenue?
Manual hemocytometers held 57.65% revenue share in 2025, supported by their installed base and low infrastructure needs.
Which hemocytometer application is growing fastest?
Cell viability assessment is forecast to grow at a 9.32% CAGR through 2031 as bioreactor-based workflows expand.
Why are disposable hemocytometers gaining use?
Disposable polymer chambers can reduce cleaning needs and support contamination control in sensitive laboratory workflows.
Which region is growing fastest for hemocytometers?
Asia-Pacific is forecast to grow at a 7.54% CAGR through 2031, supported by biopharma and laboratory infrastructure expansion.
Can hemocytometers remain useful alongside automated counters?
Yes. Direct microscopy remains useful for visual verification, low-volume work, and samples with debris, clumps, or unusual morphology.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence